Bharat Biotech in-licences GSK's Shigella vaccine candidate |...

Dununu.com Dununu

Patrocinado

Bharat Biotech in-licences GSK's Shigella vaccine candidate

RSS Feed Business

Postado

73

Bharat Biotech has in-licensed GSK's Shigella vaccine candidate, altSonflex1-2-3, aimed at combating Shigellosis in young children in low- and middle-income countries. Following promising early-stage trials by GSK, Bharat Biotech will advance the vaccine through Phase-III trials, regulatory processes, and large-scale production. This collaboration strengthens Bharat Biotech's portfolio of vaccines against diarrheal infections.

Read Full Article

Faça o login para curtir, compartilhar e comentar!

Wild elephants enter settlements, locals in panic

KANCHANPUR: Wild elephants have begun entering Jai-Parsiya village in Laljhadi Rural...

Por 0 10

NSA Ajit Doval in Russia amid Trump tariff threat: Key talks with Kremlin; will oil be on agenda?

Por 0 11

IND vs ENG: 'Even the clouds cried on the pitch' - R Ashwin slams England

Indian spinner R Ashwin has criticized England's cricket team, particularly captain Ben Stokes...

Por 0 20

'Languishes in premature retirement': Tharoor reignites call for Kohli's Test comeback

Shashi Tharoor has stirred debate by questioning Virat Kohli's Test retirement, deeming it...

Por 0 20

'I am going to exert my powers': Prosecute minors as adults? Trump warns of federal control in DC after ex-Doge staffer assaulted

President Trump expressed outrage over rising crime in Washington, DC, threatening federal...

Por 0 20